메뉴 건너뛰기




Volumn 171, Issue 12, 2012, Pages 1761-1766

Persistence of protection of hepatitis B vaccine and response to booster immunization in 2- to 12-year-old children

Author keywords

Anamnestic response; Booster vaccination; Children; HBV; Hepatitis B vaccination; Long term immunity

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B VACCINE; IMMUNOLOGIC FACTOR;

EID: 84879161966     PISSN: 03406199     EISSN: 14321076     Source Type: Journal    
DOI: 10.1007/s00431-012-1815-4     Document Type: Article
Times cited : (13)

References (37)
  • 1
    • 0141526159 scopus 로고    scopus 로고
    • Epidemiology of hepatitis B in Europe and worldwide
    • 10.1016/S0168-8278(03)00141-7
    • Alter MJ (2003) Epidemiology of hepatitis B in Europe and worldwide. J Hepatol 39:64-69
    • (2003) J Hepatol , vol.39 , pp. 64-69
    • Alter, M.J.1
  • 2
    • 54049124753 scopus 로고    scopus 로고
    • Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: A 15-year follow-up study
    • 18756185 10.1097/INF.0b013e31817702ba
    • Bialek SR, Bower WA, Novak R, Helgenberger L, Auerbach SB, Williams IT, Bell BP (2008) Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: a 15-year follow-up study. Pediatr Infect Dis J 27(10):881-885
    • (2008) Pediatr Infect Dis J , vol.27 , Issue.10 , pp. 881-885
    • Bialek, S.R.1    Bower, W.A.2    Novak, R.3    Helgenberger, L.4    Auerbach, S.B.5    Williams, I.T.6    Bell, B.P.7
  • 3
    • 0026430024 scopus 로고
    • Hepatitis B virus: A comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
    • Centers for Disease Control and Prevention
    • Centers for Disease Control and Prevention (1991) Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 40(13):1-25
    • (1991) MMWR Recomm Rep , vol.40 , Issue.13 , pp. 1-25
  • 5
    • 61849176483 scopus 로고    scopus 로고
    • Hepatitis B vaccination: The key towards elimination and eradication of hepatitis B
    • 19231008 10.1016/j.jhep.2009.01.002
    • Chen DS (2009) Hepatitis B vaccination: the key towards elimination and eradication of hepatitis B. J Hepatol 50(4):805-816
    • (2009) J Hepatol , vol.50 , Issue.4 , pp. 805-816
    • Chen, D.S.1
  • 6
    • 65249109726 scopus 로고    scopus 로고
    • Long-term humoral and cellular immune response to hepatitis B vaccine in high-risk children 18-20 years after neonatal immunization
    • 19326999 10.1089/vim.2008.0087 1:CAS:528:DC%2BD1MXjslWksro%3D
    • Chinchai T, Chirathaworn C, Praianantathavorn K, Theamboonlers A, Hutagalung Y, Bock PH, Thantiworasit P, Poovorawan Y (2009) Long-term humoral and cellular immune response to hepatitis B vaccine in high-risk children 18-20 years after neonatal immunization. Viral Immunol 22(2):125-130
    • (2009) Viral Immunol , vol.22 , Issue.2 , pp. 125-130
    • Chinchai, T.1    Chirathaworn, C.2    Praianantathavorn, K.3    Theamboonlers, A.4    Hutagalung, Y.5    Bock, P.H.6    Thantiworasit, P.7    Poovorawan, Y.8
  • 8
    • 0001566476 scopus 로고    scopus 로고
    • Are booster immunisations needed for lifelong hepatitis B immunity?
    • European Consensus Group on Hepatitis B Immunity 10.1016/S0140-6736(99) 07239-6
    • European Consensus Group on Hepatitis B Immunity (2000) Are booster immunisations needed for lifelong hepatitis B immunity? Lancet 355:561-565
    • (2000) Lancet , vol.355 , pp. 561-565
  • 9
    • 29244437488 scopus 로고    scopus 로고
    • A mathematical model to estimate global hepatitis B disease burden and vaccination impact
    • 16249217 10.1093/ije/dyi206
    • Goldstein ST, Zhou F, Hadler SC, Bell BP, Mast EE, Margolis HS (2005) A mathematical model to estimate global hepatitis B disease burden and vaccination impact. Int J Epidemiol 34(6):1329-1339
    • (2005) Int J Epidemiol , vol.34 , Issue.6 , pp. 1329-1339
    • Goldstein, S.T.1    Zhou, F.2    Hadler, S.C.3    Bell, B.P.4    Mast, E.E.5    Margolis, H.S.6
  • 10
    • 34548567080 scopus 로고    scopus 로고
    • Hepatitis B immunity in children vaccinated with recombinant hepatitis B vaccine beginning at birth: A follow-up study at 15 years
    • 17714836 10.1016/j.vaccine.2007.06.059 1:CAS:528:DC%2BD2sXhtVCnsLjI
    • Hammitt LL, Hennessy TW, Fiore AE, Zanis C, Hummel KB, Dunaway E, Bulkow L, McMahon BJ (2007) Hepatitis B immunity in children vaccinated with recombinant hepatitis B vaccine beginning at birth: a follow-up study at 15 years. Vaccine 25(39-40):6958-6964
    • (2007) Vaccine , vol.25 , Issue.39-40 , pp. 6958-6964
    • Hammitt, L.L.1    Hennessy, T.W.2    Fiore, A.E.3    Zanis, C.4    Hummel, K.B.5    Dunaway, E.6    Bulkow, L.7    McMahon, B.J.8
  • 11
    • 0032905655 scopus 로고    scopus 로고
    • A mathematical model predicting anti-hepatitis B virus surface antigen (HBs) decay after vaccination against hepatitis B
    • 10209515 10.1046/j.1365-2249.1999.00866.x 1:STN:280:DyaK1M3isF2qsg%3D%3D
    • Honorati MC, Palareti A, Dolzani P, Busachi CA, Rizzoli R, Facchini A (1999) A mathematical model predicting anti-hepatitis B virus surface antigen (HBs) decay after vaccination against hepatitis B. Clin Exp Immunol 116(1):121-126
    • (1999) Clin Exp Immunol , vol.116 , Issue.1 , pp. 121-126
    • Honorati, M.C.1    Palareti, A.2    Dolzani, P.3    Busachi, C.A.4    Rizzoli, R.5    Facchini, A.6
  • 12
    • 77949763223 scopus 로고    scopus 로고
    • Hepatitis B virus and hepatitis delta virus
    • G.L. Mandell E. John R.D. Bennet (eds) 6 Churchill Livingstone Philadelphia
    • James Koziel M, Siddiqui A (2005) Hepatitis B virus and hepatitis delta virus. In: Mandell GL, John E, Bennet RD (eds) Infectious diseases, principles and practice, 6th edn. Churchill Livingstone, Philadelphia, pp 1864-1884
    • (2005) Infectious Diseases, Principles and Practice , pp. 1864-1884
    • James Koziel, M.1    Siddiqui, A.2
  • 13
    • 77951476034 scopus 로고    scopus 로고
    • Determination of immune memory to hepatitis B vaccination through early booster response in college students
    • 20209603 10.1002/hep.23543 1:CAS:528:DC%2BC3cXntFCqtLg%3D
    • Jan CF, Huang KC, Chien YC, Greydanus DE, Davies HD, Chiu TY, Huang LM, Chen CJ, Chen DS (2010) Determination of immune memory to hepatitis B vaccination through early booster response in college students. Hepatology 51(5):1547-1554
    • (2010) Hepatology , vol.51 , Issue.5 , pp. 1547-1554
    • Jan, C.F.1    Huang, K.C.2    Chien, Y.C.3    Greydanus, D.E.4    Davies, H.D.5    Chiu, T.Y.6    Huang, L.M.7    Chen, C.J.8    Chen, D.S.9
  • 14
    • 19944432774 scopus 로고    scopus 로고
    • Hepatitis B vaccine boosters: Is there a clinical need in high endemicity populations?
    • 15610440 10.1111/j.1440-1746.2004.03398.x
    • John TJ, Cooksley G (2005) Hepatitis B vaccine boosters: is there a clinical need in high endemicity populations? J Gastroenterol Hepatol 20(1):5-10
    • (2005) J Gastroenterol Hepatol , vol.20 , Issue.1 , pp. 5-10
    • John, T.J.1    Cooksley, G.2
  • 15
    • 26644445700 scopus 로고    scopus 로고
    • Hepatitis B vaccination: To boost or not to boost?
    • 16226597 10.1016/S0140-6736(05)67544-7
    • Kao JH, Chen DS (2005) Hepatitis B vaccination: to boost or not to boost? Lancet 366(9494):1337-1338
    • (2005) Lancet , vol.366 , Issue.9494 , pp. 1337-1338
    • Kao, J.H.1    Chen, D.S.2
  • 16
    • 84856587769 scopus 로고    scopus 로고
    • Hepatitis B virus seropositivity and vaccination for children aged 0-18 in the Van Region
    • 10.5152/ced.2011.46
    • Kaya A, Erbey MF, Okur M, Sal E, Üstyol L, Bektaş SM (2011) Hepatitis B virus seropositivity and vaccination for children aged 0-18 in the Van Region. J Pediatr Inf 5:132-135
    • (2011) J Pediatr Inf , vol.5 , pp. 132-135
    • Kaya, A.1    Erbey, M.F.2    Okur, M.3    Sal, E.4    Üstyol, L.5    Bektaş, S.M.6
  • 17
    • 10644244357 scopus 로고    scopus 로고
    • Waning immunity to plasma derived hepatitis B vaccine and the need for boosters 15 years after neonatal vaccination
    • 15565627 10.1002/hep.20490
    • Lu CY, Chiang BL, Chi WK, Chang MH, Ni YH, Hsu HM, Twu SJ, Su IJ, Huang LM, Lee CY (2004) Waning immunity to plasma derived hepatitis B vaccine and the need for boosters 15 years after neonatal vaccination. Hepatology 40:1415-1420
    • (2004) Hepatology , vol.40 , pp. 1415-1420
    • Lu, C.Y.1    Chiang, B.L.2    Chi, W.K.3    Chang, M.H.4    Ni, Y.H.5    Hsu, H.M.6    Twu, S.J.7    Su, I.J.8    Huang, L.M.9    Lee, C.Y.10
  • 20
    • 80052021840 scopus 로고    scopus 로고
    • Elimination of hepatocellular carcinoma and acute hepatitis B in children 25 years after a hepatitis B newborn and catch-up immunization program
    • 21618565 10.1002/hep.24442
    • McMahon BJ, Bulkow LR, Singleton RJ, Williams J, Snowball M, Homan C, Parkinson AJ (2011) Elimination of hepatocellular carcinoma and acute hepatitis B in children 25 years after a hepatitis B newborn and catch-up immunization program. Hepatology 54(3):801-807
    • (2011) Hepatology , vol.54 , Issue.3 , pp. 801-807
    • McMahon, B.J.1    Bulkow, L.R.2    Singleton, R.J.3    Williams, J.4    Snowball, M.5    Homan, C.6    Parkinson, A.J.7
  • 21
    • 84885907957 scopus 로고    scopus 로고
    • Seroprevalence of hepatitis B and immunization status of children aged between 9 months-8 years old
    • Nalbantoǧlu B, Nalbantoǧlu A, Külcü NU, Say A (2010) Seroprevalence of hepatitis B and immunization status of children aged between 9 months-8 years old. J Child 10(3):116-121
    • (2010) J Child , vol.10 , Issue.3 , pp. 116-121
    • Nalbantoǧlu, B.1    Nalbantoǧlu, A.2    Külcü, N.U.3    Say, A.4
  • 22
    • 3142686650 scopus 로고    scopus 로고
    • Duration of hepatitis B immunity in low risk children receiving hepatitis B vaccinations from birth
    • 15247604 10.1097/01.inf.0000130952.96259.fd
    • Petersen KM, Bulkow LR, McMahon BJ, Zanis C, Getty M, Peters H, Parkinson AJ (2004) Duration of hepatitis B immunity in low risk children receiving hepatitis B vaccinations from birth. Pediatr Infect Dis J 23:650-655
    • (2004) Pediatr Infect Dis J , vol.23 , pp. 650-655
    • Petersen, K.M.1    Bulkow, L.R.2    McMahon, B.J.3    Zanis, C.4    Getty, M.5    Peters, H.6    Parkinson, A.J.7
  • 23
    • 34547687759 scopus 로고    scopus 로고
    • Differences in response to a hepatitis B vaccine booster dose among Alaskan children and adolescents vaccinated during infancy
    • 10.1542/peds.2007-0131
    • Samandari T, Fiore AE, Negus S, Williams JL, Kuhnert W, McMahon BJ, Bell BP (2007) Differences in response to a hepatitis B vaccine booster dose among Alaskan children and adolescents vaccinated during infancy. Pediatrics 120(2):373-381
    • (2007) Pediatrics , vol.120 , Issue.2 , pp. 373-381
    • Samandari, T.1    Fiore, A.E.2    Negus, S.3    Williams, J.L.4    Kuhnert, W.5    McMahon, B.J.6    Bell, B.P.7
  • 24
    • 0036678911 scopus 로고    scopus 로고
    • Persistence of antibody and immunologic memory in children immunized with hepatitis B vaccine at birth
    • 12233715 10.1097/00006454-200208000-00021
    • Seto D, West DJ, Ioli VA (2002) Persistence of antibody and immunologic memory in children immunized with hepatitis B vaccine at birth. Pediatr Infect Dis J 21(8):793-795
    • (2002) Pediatr Infect Dis J , vol.21 , Issue.8 , pp. 793-795
    • Seto, D.1    West, D.J.2    Ioli, V.A.3
  • 25
    • 35448997829 scopus 로고    scopus 로고
    • Hepatitis B seroprevalence and anamnestic response amongst Taiwanese young adults with full vaccination in infancy, 20 years subsequent to national hepatitis B vaccination
    • 17920732 10.1016/j.vaccine.2007.09.013 1:CAS:528:DC%2BD2sXht1amt7nN
    • Su FH, Cheng SH, Li CY, Chen JD, Hsiao CY, Chien CC, Yang YC, Hung HH, Chu FY (2007) Hepatitis B seroprevalence and anamnestic response amongst Taiwanese young adults with full vaccination in infancy, 20 years subsequent to national hepatitis B vaccination. Vaccine 25(47):8085-8090
    • (2007) Vaccine , vol.25 , Issue.47 , pp. 8085-8090
    • Su, F.H.1    Cheng, S.H.2    Li, C.Y.3    Chen, J.D.4    Hsiao, C.Y.5    Chien, C.C.6    Yang, Y.C.7    Hung, H.H.8    Chu, F.Y.9
  • 27
    • 84942481625 scopus 로고
    • Immunogenicity of recombinant yeast-derived hepatitis B vaccine in nonresponders to perinatal immunization
    • 8114241 10.1001/jama.1994.03510350069039 1:STN:280:DyaK2c7lvVSksQ%3D%3D
    • Tan KL, Goh KT, Oon CJ, Chan SH (1994) Immunogenicity of recombinant yeast-derived hepatitis B vaccine in nonresponders to perinatal immunization. JAMA 271:859-861
    • (1994) JAMA , vol.271 , pp. 859-861
    • Tan, K.L.1    Goh, K.T.2    Oon, C.J.3    Chan, S.H.4
  • 28
    • 0002625327 scopus 로고    scopus 로고
    • HBV infeksiyonu epidemiyolojisi
    • E. Tekeli İ BalIk (eds) Karakter Col AŞ Ankara
    • Taşyaran MA (2003) HBV infeksiyonu epidemiyolojisi. In: Tekeli E, BalIk İ (eds) Viral Hepatit. Karakter Col AŞ, Ankara, pp 121-128
    • (2003) Viral Hepatit , pp. 121-128
    • Taşyaran, M.A.1
  • 29
    • 0030979062 scopus 로고    scopus 로고
    • Integration of hepatitis B vaccination into national immunisation programmes
    • 10.1136/bmj.314.7086.1033
    • Van Damme P, Kane M, Meheus A (1997) Integration of hepatitis B vaccination into national immunisation programmes. Br Med J 314:1033-1036
    • (1997) Br Med J , vol.314 , pp. 1033-1036
    • Van Damme, P.1    Kane, M.2    Meheus, A.3
  • 30
    • 33846826801 scopus 로고    scopus 로고
    • A review of the long-term protection after hepatitis A and B vaccination
    • 17298912 10.1016/j.tmaid.2006.04.004
    • Van Damme P, Van Herck K (2007) A review of the long-term protection after hepatitis A and B vaccination. Travel Med Infect Dis 5(2):79-84
    • (2007) Travel Med Infect Dis , vol.5 , Issue.2 , pp. 79-84
    • Van Damme, P.1    Van Herck, K.2
  • 32
    • 0027122046 scopus 로고
    • Expanded programme on immunization global advisory group
    • World Health Organization
    • World Health Organization (1992) Expanded programme on immunization global advisory group. Wkly Epidemiol Rec 3:11-16
    • (1992) Wkly Epidemiol Rec , vol.3 , pp. 11-16
  • 33
    • 4644354309 scopus 로고    scopus 로고
    • Hepatitis B vaccines WHO position paper
    • World Health Organization
    • World Health Organization (2004) Hepatitis B vaccines WHO position paper. Wkly Epidemiol Rec 79:255-263
    • (2004) Wkly Epidemiol Rec , vol.79 , pp. 255-263
  • 34
    • 70349923347 scopus 로고    scopus 로고
    • Hepatitis B vaccines WHO position paper
    • World Health Organization
    • World Health Organization (2009) Hepatitis B vaccines WHO position paper. Wkly Epidemiol Rec 84:405-420
    • (2009) Wkly Epidemiol Rec , vol.84 , pp. 405-420
  • 35
    • 77949765808 scopus 로고    scopus 로고
    • Persistence of HBV vaccine's protection and response to hepatitis B booster immunization in 5- to 7-year-old children in the Kohgiloyeh and Boyerahmad Province, Iran
    • 22308120
    • Yazdanpanah B, Safari M, Yazdanpanah S (2010) Persistence of HBV vaccine's protection and response to hepatitis B booster immunization in 5- to 7-year-old children in the Kohgiloyeh and Boyerahmad Province, Iran. Hepat Mon 10(1):17-21
    • (2010) Hepat Mon , vol.10 , Issue.1 , pp. 17-21
    • Yazdanpanah, B.1    Safari, M.2    Yazdanpanah, S.3
  • 37
    • 80053613634 scopus 로고    scopus 로고
    • Presence of immune memory and immunity to hepatitis B virus in adults after neonatal hepatitis B vaccination
    • 10.1016/j.vaccine.2011.07.098
    • Zhu CL, Liu P, Chen T, Ni Z, Lu LL, Huang F, Lu J, Sun Z, Qu C (2011) Presence of immune memory and immunity to hepatitis B virus in adults after neonatal hepatitis B vaccination. Vaccine 13:7835-7841
    • (2011) Vaccine , vol.13 , pp. 7835-7841
    • Zhu, C.L.1    Liu, P.2    Chen, T.3    Ni, Z.4    Lu, L.L.5    Huang, F.6    Lu, J.7    Sun, Z.8    Qu, C.9


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.